---
title: "Ivermectin trial, Oxford University"
image: "https:\/\/i.ytimg.com\/vi\/c9bgCG5WgTQ\/hqdefault.jpg"
vid_id: "c9bgCG5WgTQ"
categories: "Education"
tags: ["physiology","nursing","NCLEX"]
date: "2022-02-10T10:22:17+03:00"
vid_date: "2022-02-09T14:58:04Z"
duration: "PT12M54S"
viewcount: "489811"
likeCount: "20535"
dislikeCount: ""
channel: "Dr. John Campbell"
---
{% raw %}Ivermectin Arm of PRINCIPLE Trial Put on Hold?<br /><br /><a rel="nofollow" target="blank" href="https://www.medpagetoday.com/special-reports/exclusives/96194">https://www.medpagetoday.com/special-reports/exclusives/96194</a><br /><br />MedPage Today, Merck<br />&quot;concluded that the probability of ivermectin providing a potentially safe and efficacious treatment option for SARS-CoV-2 infection is low and have prioritized internal efforts towards the development of alternate candidates that provide a higher probability of success for the treatment of COVID-19.&quot;<br />&quot;If clinical data emerge providing definitive evidence for a positive benefit-risk assessment of the use of ivermectin in COVID-19, we stand ready to provide our expertise and resources as needed,&quot;<br /><br />Ivermectin, PRINCIPLE trial<br /><br /><a rel="nofollow" target="blank" href="https://www.principletrial.org">https://www.principletrial.org</a><br /><br /><a rel="nofollow" target="blank" href="https://www.principletrial.org/news/ivermectin-to-be-investigated-as-a-possible-treatment-for-covid-19-in-oxford2019s-principle-trial">https://www.principletrial.org/news/ivermectin-to-be-investigated-as-a-possible-treatment-for-covid-19-in-oxford2019s-principle-trial</a><br /><br /><a rel="nofollow" target="blank" href="https://www.principletrial.org/news">https://www.principletrial.org/news</a><br /><br />Professor Chris Butler, from the University Oxford’s Nuffield Department of Primary Care Health Sciences, <br /><br />Joint Chief Investigator of the PRINCIPLE trial, said, <br /><br />‘Ivermectin is readily available globally, <br /><br />has been in wide use for many other infectious conditions so it’s a well-known medicine with a good safety profile, <br /><br />and because of the early promising results in some studies it is already being widely used to treat COVID-19 in several countries.<br /><br />International Standard Randomised Controlled Trial Number<br /><br /><a rel="nofollow" target="blank" href="https://www.isrctn.com/ISRCTN86534580?q=ivermectin&amp;filters=&amp;sort=&amp;offset=4&amp;totalResults=25&amp;page=1&amp;pageSize=10&amp;searchType=basic-search">https://www.isrctn.com/ISRCTN86534580?q=ivermectin&amp;filters=&amp;sort=&amp;offset=4&amp;totalResults=25&amp;page=1&amp;pageSize=10&amp;searchType=basic-search</a><br /><br />When is the study starting and how long is it expected to run for?<br /><br />March 2020 to September 2022<br /><br />Favipiravir<br /><br /><a rel="nofollow" target="blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713175/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713175/</a><br /><br /><a rel="nofollow" target="blank" href="https://bnf.nice.org.uk/treatment-summary/influenza.html">https://bnf.nice.org.uk/treatment-summary/influenza.html</a><br /><br />Ivermectin<br /><br /><a rel="nofollow" target="blank" href="https://bnf.nice.org.uk/drug/ivermectin.html">https://bnf.nice.org.uk/drug/ivermectin.html</a><br /><br />A double blind trial<br /><br />Independent Data Monitoring and Safety Committee<br /><br />Will pick up a signal for futility, superiority, or safety<br /><br />Will let the Trial Steering Committee know<br /><br />Then a final analysis can be conducted, followed by the release of results and data{% endraw %}
